costs, benefits, and effectiveness of pharmaceuticals and other medical technologies /
First Statement of Responsibility
edited by Frank A. Sloan.
.PUBLICATION, DISTRIBUTION, ETC
Place of Publication, Distribution, etc.
New York :
Name of Publisher, Distributor, etc.
Cambridge University Press,
Date of Publication, Distribution, etc.
1995.
PHYSICAL DESCRIPTION
Specific Material Designation and Extent of Item
xi, 273 pages :
Other Physical Details
illustrations ;
Dimensions
24 cm
INTERNAL BIBLIOGRAPHIES/INDEXES NOTE
Text of Note
Includes bibliographical references (pages 245-267) and index.
CONTENTS NOTE
Text of Note
1. Introduction / Frank A. Sloan -- 2. Evidence of effectiveness: evaluating its quality / Allan S. Detsky -- 3. Utility assessment for estimating quality-adjusted life years / Robert M. Kaplan -- 4. Measuring costs / David Dranove -- 5. From cost-effectiveness ratios to resource allocation: where to draw the line? / Milton C. Weinstein -- 6. Valuing health care benefits in money terms / Mark V. Pauly -- 7. Discounting health effects for medical decisions / W. Kip Viscusi -- 8. Statistical issues in cost-effectiveness analyses / John Mullahy and Willard Manning -- 9. Decision trees and Markov models in cost-effectiveness research / Emmett Keeler -- 10. The use of cost-effectiveness/cost-benefit analysis in actual decision making: current status and prospects / Frank A. Sloan and Christopher J. Conover.
0
SUMMARY OR ABSTRACT
Text of Note
Papers describing the state of the art in cost benefit and cost effectiveness analysis.